Build a GERD workup and anti-reflux pathway: alarm features, pH testing, manometry, and…
- User
Build a GERD workup and anti-reflux pathway: alarm features, pH testing, manometry, and options.
- Assistant
GERD Workup and Anti-Reflux Pathway
This pathway follows ACG/AGA guidelines for Gastroesophageal Reflux Disease (GERD) management in adults with typical symptoms (heartburn, regurgitation). It emphasizes risk stratification, diagnostics, and escalation. Always individualize based on patient factors (e.g., age >60, comorbidities).
1. Initial Evaluation
- History: Confirm typical symptoms (epigastric pain, regurgitation). Assess frequency/severity (e.g., GERD-Q score ≥8 suggests GERD).
- Risk factors: Obesity, hiatal hernia, smoking, alcohol, NSAIDs, pregnancy.
- Exam: BMI, epigastric tenderness, oral/succussion splash (suggests gastroparesis).
- Labs (routine): CBC (anemia), BUN/Cr (pre-PPI), H. pylori test if dyspepsia-dominant.
Proceed to Alarm Features Screening
2. Alarm Features (Red Flags) → Urgent Upper Endoscopy (EGD)
If ANY present → EGD within 24-72 hours (or STAT if acute bleed).
Alarm Feature Rationale Dysphagia/odynophagia Esophageal stricture, eosinophilic esophagitis, cancer Unintentional weight loss (>10% body weight) Malignancy, obstruction Iron-deficiency anemia Occult bleed (ulcer, cancer) Persistent vomiting/hematemesis Obstruction, Mallory-Weiss, varices Family h/o esophageal/caastric cancer Genetic risk Age >60 + new symptoms Higher malignancy risk Palpable mass/succussion splash Gastric outlet obstruction - EGD Findings Guide Next Steps:
Finding Management LA Grade C/D esophagitis PPI x8 weeks + re-scope if no heal Barrett's esophagus Surveillance ± ablation Peptic stricture Dilation + PPI Mass/adenoca Oncology referral Normal Functional heartburn → pH testing
No Alarm Features → Stepwise Pathway
3. Empiric Therapy Trial (No Alarm Features)
-
Lifestyle (All Patients):
Intervention Details Weight loss >10% if BMI >25 Elevate HOB 6-8 inches Avoid triggers Late meals (<3h before bed), alcohol, chocolate, caffeine, spicy/fatty foods Smoking cessation - -
PPI Trial (BID dosing x8 weeks, e.g., omeprazole 40mg BID):
- Response (>50% symptom relief) → Maintenance PPI (lowest effective dose, e.g., daily). Taper annually.
- No/Partial Response → Refractory GERD → Diagnostic Testing (below).
4. Diagnostic Testing for Refractory/Pre-Op GERD
Test in sequence or combined based on need (e.g., pre-surgery: manometry + pH).
Refractory Symptoms → ├── EGD (if not done) → Normal? → pH-Impedance └── Atypical Symptoms (cough, laryngitis) → pH-Impedance firstpH Testing (Gold Standard for Reflux Confirmation)
-
24-96h Wireless pH (Bravo) or Transnasal Catheter + Multichannel Intraluminal Impedance (MII).
-
Off PPI 7 days (preferred) or On PPI (if surgery candidate).
-
Key Metrics:
Abnormal Result Interpretation AET >6% (total) / >4% upright / >1.5% supine True GERD Symptom Association Probability (SAP) >95% Reflux-related symptoms Normal AET + Positive SAP Hypersensitive esophagus Normal AET/SAP Functional heartburn/reflux hypersensitivity -
Next: Positive → Optimize medical Rx or surgery. Negative → Neuromodulators (e.g., TCA), CBT.
Manometry (High-Resolution Esophageal Manometry - HRM)
-
Indications: Pre-anti-reflux surgery, dysphagia, suspected achalasia/motility disorder.
-
Key Findings:
Abnormality Implication LES pressure <10 mmHg Hypotensive LES (surgery risk) Failed peristalsis (>50%) Ineffective motility (tailor surgery) Hypercontractile (>8,000 mmHg·s·cm) Jackhammer (avoid tight wrap) Achalasia pattern Not GERD → POEM/Heller -
Normal HRM → Safe for fundoplication.
5. Treatment Options (Escalation Ladder)
Lifestyle/PPI Failure → ├── Optimize PPI (BID, switch agent) ├── Adjuncts: H2RA night, baclofen 10-20mg TID (reflux barrier), sucralfate └── Refractory → Test → Surgery/AdvancedTier Options Candidates Efficacy/Evidence Medical (1st/2nd Line) PPI BID, Alginate (Gaviscon Advance) Mild-moderate 70-80% response Neuromodulation Low-dose TCA (amitriptyline 10-25mg qHS), SSRI, Gabapentin Hypersensitive/Functional 50-60% symptom relief Endoscopic TIF 2.0 (Transoral Incisionless Fundoplication), Stretta (RF), MUSE (Medigus) Mild, PPI intolerant 60-70% at 1yr (less durable) Surgical (Definitive) Laparoscopic Nissen Fundoplication (360°), Toupet (270° partial), Dor (anterior) Confirmed GERD + hiatal hernia, young, surgery fit 85-90% long-term; Tailor by manometry (loose wrap if motility poor) Emerging LINX (Magnetic Sphincter Augmentation) Small hernia, intact motility 80-90% PPI cessation Pre-Surgery Checklist
- EGD (rule out Barrett's/stricture).
- HRM (motility).
- pH-MII (confirm reflux, symptom correlation).
- Barium swallow (hiatal hernia size).
Monitoring & Follow-Up
- Response Assessment: 4-8 weeks post-initiation.
- Surveillance: Barrett's → EGD q3yrs (no dysplasia).
- Refractory Red Flags: Reassess for non-GERD (eosinophilic esophagitis, rumination, gastroparesis → Scintigraphy).
This pathway minimizes unnecessary testing while ensuring safety. Consult GI for complex cases. Data: ACG 2022 Guidelines.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.